Roivant Sciences Ltd. logo ROIV - Roivant Sciences Ltd.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 14
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $36.17 DETAILS
HIGH: $42.00
LOW: $30.00
MEDIAN: $37.00
CONSENSUS: $36.17
UPSIDE: 20.73%
Metric 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3
Revenue
Revenue 2.5 2.0 1.6 2.2 7.6 9.0 4.5 8.0 28.9 15.6 3.6 21.6 27.4 17.1
Cost of Revenue 0.3 0.7 0.1 0.2 0.2 0.3 0.2 0.2 4.4 0.2 0.2 4.2 9.4 8.3
Gross Profit 2.2 1.3 1.5 2.0 7.4 8.8 4.2 7.8 24.5 15.4 3.4 17.4 18.0 8.7
Operating Expenses
R&D Expenses 198.9 165.4 164.6 152.9 145.2 141.6 143.1 120.5 120.9 108.1 114.8 125.1 131.9 125.5
SG&A Expenses 158.2 175.1 143.1 134.0 147.1 141.5 202.9 99.9 169.6 128.2 88.6 156.2 120.3 163.5
Other Expenses 0 0 0 0 0 0 0 (110.4) 0 (5,348.4) 13.9 12.5 0 0
Operating Expenses 357.2 340.5 307.7 286.9 292.3 283.1 346.0 110.0 290.5 (5,112.1) 217.3 293.8 252.2 289.1
Operating Income
Operating Income (355.0) (339.2) (306.2) (284.9) (285.0) (274.4) (341.7) (102.2) (266) 5,127.5 (213.9) (276.4) (234.2) (280.3)
Interest Expense 0 0 0 0 0 0 0 13.4 9.4 9.2 8.9 8.6 8.4
Interest Income 41.2 43.3 45.3 48.3 54.6 61.9 69.8 72.1 83.5 32.0 14.3 16.7 14.3 10.2
Profitability
EBITDA (354.4) (338.5) (305.3) (283.8) (283.5) (271.5) (336.9) (207.7) (179.1) (215.6) (194.4) (311.3) (163.1) (366.7)
EBIT (355.0) (339.2) (306.2) (284.9) (285.0) (274.4) (341.7) (212.6) (184.3) (221.0) (199.9) (317.2) (170.6) (373.6)
Income Before Tax 454.1 (290.4) (159.0) (269.3) (203.1) (234.5) (224.4) (19.6) (191.5) 5,153.5 (241.4) (326.1) (179.2) (382.1)
Income Tax Expense 98.4 23.3 7.0 4.6 49.3 (25.6) 12.5 12.0 (9.0) 22.4 3.2 1.8 (3.8) 2.8
Net Income 303.0 (265.9) (113.5) (223.4) (206.5) 169.4 (230.2) 95.3 (151.1) 5,096.2 (304.3) (291.8) (33.6) (352.0)
Per Share Data
EPS (Basic) 0.43 -0.38 -0.17 -0.33 -0.29 0.23 -0.31 0.13 -0.19 6.37 -0.40 -0.38 -0.05 -0.49
EPS (Diluted) 0.37 -0.38 -0.17 -0.33 -0.29 0.23 -0.31 0.12 -0.19 6.03 -0.40 -0.38 -0.05 -0.49
Shares Outstanding 702.1 696.9 680.9 680.3 707.3 722.7 735.5 735.8 802.9 800.6 770.2 759.3 742.5 713.3
Metric 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3
Current Assets
Cash & Cash Equivalents 1,423.1 1,478.3 1,237.0 1,238.5 2,715.4 1,990.7 1,958.6 5,683.9 6,535.7 6,670.8 1,413.7 1,439.4 1,681.8 1,531.4
Short-Term Investments 2,872.6 3,051.7 3,148.8 3,264.7 2,171.5 3,155.8 3,428.0 0 5.4 0 0 0 0 0
Net Receivables 789.8 0 0 0 0 143.8 22.7 215.2 82.8 63.2 54.6 39.9 32.7 29.5
Inventory 0 0 0 0 0 0 0 34.0 35.3 5.2 4.9 4.2 2.8 0
Other Current Assets 81.9 129.9 125.8 112.6 113.2 16.0 336.9 11.1 17.6 14.9 17.7 13.0 20.4 15.9
Total Current Assets 5,167.4 4,659.9 4,511.6 4,615.8 5,000.1 5,364.0 5,801.1 6,001.5 6,731.8 6,806.7 1,551.6 1,561.2 1,798.6 1,646.2
Non-Current Assets
Property, Plant & Equipment 92.4 97.0 110.8 101.9 101.1 104.5 56.7 63.2 66.0 68.8 73.1 87.9 92.3 91.9
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 136.0 137.8 150.4 140.6 145.0 144.9 146.1
Long-Term Investments 415.9 433.9 412.3 283.8 302.9 290.0 311.4 272.4 247.8 239.9 259.9 306.5 314.6 282.1
Other Non-Current Assets 33.0 34.6 27.8 31.1 32.9 33.9 36.9 23.4 39.1 46.8 40.3 36.0 39.2 36.6
Total Non-Current Assets 560.7 565.5 551.0 416.9 436.9 428.4 404.9 494.9 490.7 505.9 513.9 575.5 591.0 556.7
Total Assets 5,728.0 5,225.4 5,062.6 5,032.6 5,436.9 5,792.3 6,206.0 6,496.4 7,222.5 7,312.7 2,065.5 2,136.6 2,389.6 2,203.0
Current Liabilities
Account Payables 18.0 13.3 15.1 11.6 23.7 23.7 25.1 27.7 53.2 35.2 44.1 50.0 37.8 48.0
Short-Term Debt 11.1 10.4 0 0 9.8 0 0 21.5 12 45.7 59.9 55.8 54.5 49.6
Deferred Revenue 0 0 0 0 1.2 0 3.4 2.7 4.2 4.7 5.8 10.6 12.4 7.8
Other Current Liabilities 119.1 121.1 109.8 30.7 53.9 68.1 440.2 101.9 85.9 59.6 123.6 107.5 111.9 91.3
Total Current Liabilities 281.2 152.0 133.9 113.9 149.4 141.5 556.2 215.0 266.8 244.9 265.5 245.0 272.4 244.3
Non-Current Liabilities
Long-Term Debt 0 98.5 0 0 0 0 0 311.7 430.6 403.3 389.4 385.1 375.5 375.1
Deferred Tax Liabilities 19.4 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 38.7 (97.8) 33.4 12.5 10.0 24.4 26.5 28.5 29.3 32.8 36.3 120.6 77.0 101.5
Total Non-Current Liabilities 154.4 99.2 123.3 102.8 100.3 114.9 69.7 386.1 507.2 483.2 474.4 557.5 509.6 531.6
Total Liabilities 435.6 251.1 257.1 216.7 249.7 256.4 626.0 601.2 774.0 728.1 739.9 802.5 782.0 775.8
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Retained Earnings (501.8) (695.0) (429.1) (315.6) 116.1 460.4 395.6 671.5 576.2 727.3 (4,368.9) (4,064.6) (3,772.8) (3,739.1)
Accumulated Other Comprehensive Income 4.4 20.6 19.6 17.1 9.4 8.1 (18.0) (17.9) (4.1) (27.8) (3.1) (6.6) (2.6) (0.7)
Total Stockholders' Equity 4,527.4 4,269.3 4,362.3 4,345.6 4,687.6 5,189.5 5,153.0 5,435.3 5,968.6 6,089.8 948.5 910.7 1,157.8 955.5
Total Liabilities & Equity 5,728.0 5,225.4 5,062.6 5,032.6 5,436.9 5,792.3 6,206.0 6,496.4 7,222.5 7,312.7 2,065.5 2,136.6 2,389.6 2,203.0
Debt Metrics
Total Debt 107.4 207.4 98.8 99.7 100.2 100.3 52.7 379.1 499.7 506.6 498.0 492.6 487.1 479.6
Net Debt (1,315.7) (1,270.8) (1,138.2) (1,138.8) (2,615.2) (1,890.4) (1,905.9) (5,304.9) (6,036.0) (6,164.2) (915.7) (946.7) (1,194.8) (1,051.8)
Metric 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3
Operating Activities
Net Income 355.7 (313.7) (113.5) (273.9) (252.4) 118.1 (279.9) 57.5 (63.6) 5,072.7 (217.9) (327.8) (148.2) (384.9)
Depreciation & Amortization 30.2 (8.0) 0.9 1.1 1.4 2.9 4.8 4.9 2.0 5.4 7.3 5.8 7.5 5.2
Stock-Based Compensation 77.2 105.0 0 82.2 83.5 83.7 71.7 50.2 0 54.3 0 49.3 0 57.7
Change in Working Capital (601.1) 9.4 7.1 (37.2) 34.5 (53.1) 10.3 (68.7) 16.0 21.2 17.1 (35.2) 21.2 2.7
Other Non-Cash Items (25.9) 10.9 (80.1) 23.4 (39.6) (358.8) (73.7) (236.7) (62.9) (5,364.0) (3.0) 58.1 (59.6) 96.7
Operating Cash Flow (163.8) (196.5) (185.7) (204.4) (172.6) (207.3) (266.8) (192.8) (108.5) (210.5) (196.4) (249.9) (179.1) (222.6)
Investing Activities
Capital Expenditure (1.3) 4.9 (7.8) (4.0) (0.8) (1.8) (1.0) (1.0) (0.3) (0.4) (0.3) (0.4) (1.6) (0.5)
Acquisitions 0 0 0 0 74.9 44.0 0 0 (5,234.2) 0 (36.2) 0 0 (3.1)
Purchases of Investments 3,792.1 (1,013.7) (976.7) (1,801.7) 0 (658.5) (3,403.0) 0 0 0 0 0 0 0
Sales/Maturities of Investments (2,982.9) 1,120.4 1,105 720 1,000 960 0 0 5,233.4 0 0 0 0 0
Other Investing Activities (673.7) 37.1 0 0 0.1 110.4 110.4 0 8.1 5,233.4 0.0 0.5 115.2 0.1
Investing Cash Flow 134.2 148.7 120.4 (1,085.7) 1,074.2 454.1 (3,293.6) (1.0) 6.9 5,233.0 (36.5) 0.1 113.6 (3.5)
Financing Activities
Net Debt Issuance 0 0 0 0 0 (49.1) (1.8) (1.8) (7.7) (7.7) (7.6) (7.8) (8.0) (7.4)
Stock Repurchased (111.2) 0 0 (208.3) (295.4) (243.3) (106.1) (648.4) 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 (6) 0 0 0
Other Financing Activities 30.5 (23.9) (6.5) 20.5 5.5 19.5 (1.2) (10.4) (28.6) 5.6 (0.1) 15.3 (1.4) (0.5)
Financing Cash Flow (29.5) 288.9 62.6 (187.8) (177.2) (273.0) (109.1) (660.6) (32.6) 236.6 207.9 7.5 210.3 154.5
Cash Position
Net Change in Cash (57.8) 241.6 (1.4) (1,477.1) 724.0 (27.2) (3,664.4) (857.1) (178.0) 5,262.3 (25.7) (242.5) 150.4 (71.6)
Cash at Beginning 1,480.9 1,239.3 1,240.7 2,725.7 2,001.7 2,028.9 5,693.3 6,550.4 6,676.0 1,423.2 1,439.4 1,692.1 1,531.4 1,612.6
Cash at End 1,423.1 1,480.9 1,239.3 1,248.6 2,725.7 2,001.7 2,028.9 5,693.3 6,498.0 6,685.5 1,413.7 1,449.6 1,681.8 1,541.0
Free Cash Flow (165.1) (191.5) (193.5) (208.4) (173.4) (209.1) (267.8) (193.8) (108.8) (210.8) (196.7) (250.3) (180.7) (223.1)
Key Metrics 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3
Income Statement
Revenue 2.5 2.0 1.6 2.2 7.6 9.0 4.5 8.0 28.9 15.6 3.6 21.6 27.4 17.1
Gross Profit 2.2 1.3 1.5 2.0 7.4 8.8 4.2 7.8 24.5 15.4 3.4 17.4 18.0 8.7
Operating Income (355.0) (339.2) (306.2) (284.9) (285.0) (274.4) (341.7) (102.2) (266) 5,127.5 (213.9) (276.4) (234.2) (280.3)
Net Income 303.0 (265.9) (113.5) (223.4) (206.5) 169.4 (230.2) 95.3 (151.1) 5,096.2 (304.3) (291.8) (33.6) (352.0)
EPS (Diluted) 0.37 -0.38 -0.17 -0.33 -0.29 0.23 -0.31 0.12 -0.19 6.03 -0.40 -0.38 -0.05 -0.49
Balance Sheet
Cash & Equivalents 1,423.1 1,478.3 1,237.0 1,238.5 2,715.4 1,990.7 1,958.6 5,683.9 6,535.7 6,670.8 1,413.7 1,439.4 1,681.8 1,531.4
Total Assets 5,728.0 5,225.4 5,062.6 5,032.6 5,436.9 5,792.3 6,206.0 6,496.4 7,222.5 7,312.7 2,065.5 2,136.6 2,389.6 2,203.0
Total Debt 107.4 207.4 98.8 99.7 100.2 100.3 52.7 379.1 499.7 506.6 498.0 492.6 487.1 479.6
Stockholders' Equity 4,527.4 4,269.3 4,362.3 4,345.6 4,687.6 5,189.5 5,153.0 5,435.3 5,968.6 6,089.8 948.5 910.7 1,157.8 955.5
Cash Flow
Operating Cash Flow (163.8) (196.5) (185.7) (204.4) (172.6) (207.3) (266.8) (192.8) (108.5) (210.5) (196.4) (249.9) (179.1) (222.6)
Capital Expenditure (1.3) 4.9 (7.8) (4.0) (0.8) (1.8) (1.0) (1.0) (0.3) (0.4) (0.3) (0.4) (1.6) (0.5)
Free Cash Flow (165.1) (191.5) (193.5) (208.4) (173.4) (209.1) (267.8) (193.8) (108.8) (210.8) (196.7) (250.3) (180.7) (223.1)